$VSTR ValueSetters Announces Positive Operating Profit and

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
299
$VSTR ValueSetters Announces Positive Operating Profit and Shareholder Conference Call
GlobeNewswire•March 18, 2019

Highlights:

Operating profit of $17,548
Net income of $12,391
175% increase in revenues vs. 3Q18
$44,144 increase in cash balance vs. 4/30/18
Positive operating cash flow

BOSTON, MA, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ValueSetters, Inc. (VSTR) announced positive operating earnings of $17,548 for the third quarter of fiscal 2019 and net income of $12,391. “We were pleased to report an operating profit this quarter, as a direct result of the strong growth in our consulting business,” said Cecilia Lenk, CEO. “Now that we have a proven track record in marketing private capital offerings, demand for our services has increased. In addition, we are receiving referrals from existing clients, which is helping to drive strength in our pipeline. As a result, we were able to grow sales by 175% vs. third quarter of last year and by 77% sequentially. We remain optimistic about our future growth prospects.”

We will be holding a conference call to review both our strategic outlook and third quarter earnings on Wednesday, March 27th at 12 p.m. ET. To access the call, dial either 800-346-7359 or 973-528-0008 and provide code 698785 to the operator. The name of the call is ValueSetters Earnings.

A slide presentation will be added to our website prior to the call and will be available on the Investors page, under Events & Presentations https://valuesetters.com/events-and-presentations.

For additional disclosure regarding operating results, please refer to the Quarterly Report on Form 10-Q for the period ended January 31, 2019, which has been filed with the Securities and Exchange Commission.

About ValueSetters:
Led by a team of professional investors, digital marketing experts, and technology specialists, ValueSetters is a publicly-traded boutique advisory firm with unique expertise in helping early stage companies raise capital over the internet. The company also provides technology consulting services as well as strategic advice to help companies grow and evolve to meet the challenges of today's marketplace. For more information, visit our website at http://valuesetters.com.

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Read More: https://investorshangout.com/post/view?id=540...z5kDYP1euO
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading